Skip to content

Author

Emad Almomani

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Barriers and facilitators for conducting and implementing health technology assessment in Jordan: researchers and decision-makers’ perspectives

Abstract Objectives Health technology assessment (HTA) is a multidisciplinary approach that evaluates the clinical data and cost-effectiveness of health technologies within broader policy and societal contexts. This study aimed to identify barriers and facilitators to conducting HTA and implementing its findings in Jor...

R. Mousa, Samar J. Melhem, S. Alaujan et al. · 0 citations
Review Open access Jul 2026

Consideration of intersectoral costs and benefits in health economic evaluations of pneumococcal conjugate vaccines: a systematic review

Inclusion of ICBs, except for serotype replacement, showed favorable cost-effectiveness results and provided a framework for identifying the intersectoral costs and benefits for the health economic evaluation of PCVs in children and adults.

Emad Almomani, Musa Dukuray, I. M. van der Putten et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.